Table 3. Patient characteristics of patients with cirrhosis.

Parameter	Patients
Epidemiology
Patients n	65
Gender, m/f (%)	42/23 (64.6/35.4)
Age, median, range	75 (25–79)
Etiology of liver disease
Alcohol abuse, n (%)	33 (50.8)
Hepatitis C, n (%)	14 (21.5)
Hepatitis B, n (%)	7 (10.8)
NASH1, n (%)	1 (1.5)
Cryptogenic, n (%)	6 (9.2)
Autoimmune, n (%)	4 (6.2)
Child-Pugh score
A, n (%)	19 (29.2)
B, n (%)	23 (35.4)
C, n (%)	23 (35.4)
MELD2, median, range	16, 7–40
Laboratory results
Sodium (mmol/l), median, range	139, 128–148
ALT3 (U/l), median, range	31, 2–248
AST4 (U/l), median, range	52, 18–415
GGT5 (U/l), median, range	98, 20–1178
ALP6 (U/l), median, range	116, 36–504
Bilirubin (mg/dl), median, range	2.5, 0.2–51.0
Albumin (mg/dl), median, range	3.3, 1.9–5.2
INR7, mean, median, range	1.47, 0.85–4.2
Creatinine (mg/dl), median, range
CRP8 (mg/dl), median, range

Abbreviations:

¹NASH, non-alcoholic steatohepatitis;

²MELD, model of end stage liver disease;

³ALT, alanine aminotransferase,

⁴AST, aspartate aminotransferase;

⁵GGT, gamma-glutaryl-transferase;

⁶ALP, alkaline phosphatase;

⁷INR, internationalized ratio;

⁸CRP, C-reactive protein;